TITLE
Gefitinib effect on various non-small cell lung cancer cell lines (HG-U133A)

SUMMARY
Analysis of baseline non-small cell lung cancer (NSCLC) cell lines with a broad range of sensitivity to the anticancer drug gefitinib. Gefitinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). Results used to define a gene expression signature of gefitinib sensitivity.

ORGANISM
Homo sapiens

PLATFORM
GPL96 : [HG-U133A] Affymetrix Human Genome U133A Array

CITATIONS
Coldren CD, Helfrich BA, Witta SE, Sugita M et al. Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines. Mol Cancer Res 2006 Aug;4(8):521-8. PMID:Â  16877703

